This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Groves, R. W. Articles by MacDonald, D. M. Search for Related Content PubMed PubMed Citation Articles by Groves, R. W. Articles by MacDonald, D. M.

American Journal of Pathology, Vol 143, 1220-1225, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Expression of selectin ligands by cutaneous squamous cell carcinoma

RW Groves, MH Allen, EL Ross, G Ahsan, JN Barker and DM MacDonald
Laboratory of Applied Dermatopathology, St. John's Institute of Dermatology, UMDS, Guy's Hospital, London, United Kingdom.

Recent evidence suggests that interactions between endothelial selectins and tumor surface selectin ligands may be of importance in cancer metastasis. To investigate the role of such mechanisms in cutaneous tumors, whole skin biopsies were examined immunohistochemically for a variety of selectin ligands including sialyl-Lewis-X, sialyl-Lewis-A (S-Le(a)), sulfatides, and CD15. In 12 of 12 squamous cell carcinomas (SCCs), there was expression of sialyl- Lewis-X and CD15, but no tumor expressed S-Le(a). Occasional keratinocytes in eight of 12 SCCs expressed sulfatides. All selectin ligands were absent on keratinocytes in basal cell carcinomas (BCCs, n = 8) and normal skin (n = 8), with the exception of one BCC that expressed S-Le(a). E-selectin was not present in normal skin, but was strongly expressed by dermal endothelium in both SCC and BCC. Keratinocyte cell lines A431, HaCaT, and SVK14 were investigated by flow cytometry, which demonstrated sialyl-Lewis-X and S-Le(a) expression by all three, whereas normal human keratinocytes did not express these molecules. These findings suggest a potential role for selectin-mediated events in early and late metastasis, and differential expression of these ligands by BCC and SCC may explain the relatively low metastatic potential of the former.

This article has been cited by other articles:

				M. Schuster, P. Umana, C. Ferrara, P. Brunker, C. Gerdes, G. Waxenecker, S. Wiederkum, C. Schwager, H. Loibner, G. Himmler, et al. Improved Effector Functions of a Therapeutic Monoclonal Lewis Y-Specific Antibody by Glycoform Engineering Cancer Res., September 1, 2005; 65(17): 7934 - 7941. [Abstract] [Full Text] [PDF]

				T. M. Carlos Leukocyte recruitment at sites of tumor: dissonant orchestration J. Leukoc. Biol., August 1, 2001; 70(2): 171 - 184. [Abstract] [Full Text] [PDF]

				J. Luo, G. Paranya, and J. Bischoff Noninflammatory Expression of E-Selectin Is Regulated by Cell Growth Blood, June 1, 1999; 93(11): 3785 - 3791. [Abstract] [Full Text] [PDF]